FDA reports 22 recalls for particulate as of September 14, 2014. Particulate do matter, as pointed out by John Johnson, NSF Health Sciences.1 Particulate in parenteral is an issue of safety, but impact manufacturers in many other ways. Perceived quality Cost of recall Cost of reprocessing Increased regulatory surveillance Now, with the advent of USP <787> Subvisible ParticulateMatter in Protein Injections, manufacturers are asked do more; not just testing for particulate, … [Read More...]
New Discounts on CELLTREAT®
CELLTREAT Scientific Products has reduced many prices for 2013. Biofluid Focus celebrates this by offering a 10% discount on all CELLTREAT products (except 3D culture products).
Click here to go to the CELLTREAT main page.